📊 Evidence-Based Reference

Silverstreak Hydrophilic Guidewire

Micro Therapeutics, Inc.

Product: SilverSpeedTM — all models and sizes

Contact a rep Compare similar devices

Summary: The Silverstreak Hydrophilic Guidewire is a medical device used primarily for facilitating catheter placement in endovascular procedures. Key evidence highlights its role in reducing procedural complications.

FDA Clearance Information

Pathway ? 510(k)
Number ? K982543 ↗
Decision Date ? December 11, 1998
Product Code ? DQX Wire, Guide, Catheter
Device Class ? Class 2
Evidence ? 419 studies

The Silverstreak Hydrophilic Guidewire was cleared by the FDA through the 510(k) pathway on December 11, 1998. It is manufactured by Micro Therapeutics and classified as a Class 2 device.

What It Is

The Silverstreak Hydrophilic Guidewire is designed to assist in the navigation and placement of catheters within the vascular system. Its hydrophilic coating enhances maneuverability and reduces friction during endovascular procedures.

FDA-Cleared Indications

  • Used to facilitate the placement and positioning of catheters within the vascular system.
  • Used as a guide for catheter navigation during endovascular procedures.
  • The product code identifies it as a catheter guidewire regulated under 21 CFR 870.1330.

Clinical Applications

  • Guiding catheters through the vascular system during diagnostic angiography.
  • Supporting catheter placement for endovascular interventions.
  • Navigating tortuous or complex vascular anatomy when catheter positioning is required.
  • Facilitating catheter exchanges during vascular procedures.

Reported off-label uses

  • Guidewire assistance during selected nonvascular catheter procedures, such as endoscopic retrograde cholangiopancreatography, when the specific product labeling and local practice permit it.
  • Guidewire assistance during selected embolization procedures, such as uterine artery embolization, when used in accordance with institutional protocols and applicable labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes a mix of study types such as RCTs, prospective, and retrospective studies, with a total of 10 studies reviewed. The studies range from 2022 to 2023, focusing on various clinical applications of hydrophilic guidewires.

Reported Outcomes

Published studies report that the use of hydrophilic guidewires, like the Silverstreak, can facilitate catheter advancement and improve procedural success rates in endovascular treatments. They are associated with reduced procedural time and improved access in challenging anatomical situations.

Safety Profile

Reported complications include the potential for polymer coating fragmentation, which may lead to embolic events. However, the overall incidence of serious adverse events is low, with most complications being manageable with standard clinical interventions.

Evidence Limitations

Current evidence is limited by the small sample sizes and the lack of long-term follow-up data in many studies. Further research is needed to fully understand the long-term safety and efficacy of hydrophilic guidewires in diverse patient populations.

Practical Considerations

  • The appropriate wire diameter, length, tip shape, and stiffness depend on the catheter, access route, target anatomy, and procedure.
  • The hydrophilic coating must be wetted according to the instructions for use; dry handling can increase friction and may damage the coating.
  • Use only with compatible catheters and accessories. Do not force the wire if resistance, entrapment, or unusual movement occurs.
  • MRI safety status is product- and model-specific and should be confirmed in the current manufacturer labeling; do not assume that a guidewire is MRI safe.
  • Potential complications include vascular injury, perforation, dissection, thrombosis, embolization, infection, and device fracture or coating separation.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Silverstreak Hydrophilic Guidewire?

The guidewire is indicated for use in endovascular procedures requiring catheter placement, such as neuroendovascular therapy and uterine artery embolization.

What outcomes have been reported in clinical studies?

Studies have shown improved procedural success rates and reduced time for catheter placement when using hydrophilic guidewires.

What complications have been reported?

Safety data indicates potential complications such as polymer coating fragmentation, which may cause embolic events, though these are rare.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you